EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Coretech 5's enterprise value is €0.36 Mil.
Coretech 5's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00 Mil. Therefore, Coretech 5's EV-to-Revenue for today is .
The historical rank and industry rank for Coretech 5's EV-to-Revenue or its related term are showing as below:
During the past 9 years, the highest EV-to-Revenue of Coretech 5 was 3145.64. The lowest was 171.10. And the median was 231.30.
XPAR:MLCOT's EV-to-Revenue is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.275 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-06-09), Coretech 5's stock price is €0.02.
Coretech 5's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00. Therefore, Coretech 5's PS Ratio for today is .
Coretech 5 EV-to-Revenue Historical Data
The historical data trend for Coretech 5's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Coretech 5's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Coretech 5's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coretech 5's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Coretech 5's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Coretech 5's EV-to-Revenue falls into.
Coretech 5's current Enterprise Value is €0.36 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Coretech 5's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coretech 5's share price for today is €0.02.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2022 was €0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coretech 5 EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Coretech 5's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Coretech 5 Formerly Gour Medical AG is a pharmaceutical company. It develops and markets veterinary medicines and specialist pet. Its products include food supplements or nutraceuticals or related medical devices. The products are dedicated to the treatment of pain, allergies, behavioral disorders and improvement of quality of life. It sells its product under the brand Weedley.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XPAR:MLCOT has been successfully added to your 